Glucagon News and Research

RSS
Newer Type 2 diabetes medications could reduce kidney, heart disease risks

Newer Type 2 diabetes medications could reduce kidney, heart disease risks

Glucagon resistance: A new biological concept in the fight against diabetes

Glucagon resistance: A new biological concept in the fight against diabetes

Study shows fatty liver disease is a significant risk factor for COVID-19 hospitalization

Study shows fatty liver disease is a significant risk factor for COVID-19 hospitalization

Negligible ACE2 expression in human beta-cells

Negligible ACE2 expression in human beta-cells

New approach to combination drug design could be applied to disease therapies beyond diabetes

New approach to combination drug design could be applied to disease therapies beyond diabetes

Novel drug candidate offers a major advance in the treatment for diabetes

Novel drug candidate offers a major advance in the treatment for diabetes

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Chemist develops new drug to treat type 2 diabetes without undesired side effects

GLP-1-based medicine for diabetic patients does not cause pancreatitis

GLP-1-based medicine for diabetic patients does not cause pancreatitis

Single-cell RNA-seq addresses key question in islet cell biology and diabetes research

Single-cell RNA-seq addresses key question in islet cell biology and diabetes research

New two-in-one shot could make it easier for diabetics to control their blood sugar

New two-in-one shot could make it easier for diabetics to control their blood sugar

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

New potential treatment candidate identified for early type 2 diabetic retinopathy

New potential treatment candidate identified for early type 2 diabetic retinopathy

Type 2 diabetics secrete too much glucagon when α-cells become insulin resistant

Type 2 diabetics secrete too much glucagon when α-cells become insulin resistant

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

People with type 2 diabetes and heart disease may benefit from newer therapies

Drone delivers insulin for diabetic patient living in a remote community

Drone delivers insulin for diabetic patient living in a remote community

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

Yale discovery has implications for treatment of diabetes and non-alcoholic fatty liver disease

Yale discovery has implications for treatment of diabetes and non-alcoholic fatty liver disease

Targeted combinatorial drug treatment restores beta cell function in mice

Targeted combinatorial drug treatment restores beta cell function in mice

Understanding the genetic background of idiopathic ketotic hypoglycemia

Understanding the genetic background of idiopathic ketotic hypoglycemia